doi:10.1056/NEJMoa2206038 Bellini A, Keegan THM, Li Q, et al
ACCF/AHA 2011 Health Policy Statement on Therapeutic Interchange and Substitution A Report of the American College of Cardiology Foundation Clinical Quality Committee
Bottom line Compounded semaglutide should only be considered when made by a reputable, U.S.-licensed compounding pharmacy
Ongoing studies are aimed at determining the potential relevance of NNMT inhibition to cognitive performance and neurological research
Clinical trial data supports safety for up to two years of continuous use, though longer-term data remains limited since the medication received FDA approval recently
Oral glutathione is minimally absorbed, however, IV glutathione can aggressively replete cellular glutathione levels and reduce inflammation